Issue link: https://www.e-digitaleditions.com/i/1521797
This section provides information that may be useful in research and development or manufacturing. Content is provided by the companies listed. No endorsement or preference is intended. 32 June 2024 Inhalation SPECIAL SECTION Filling and Packaging This section of Inhalation provides information that may be useful in research and development or manufacturing. Content is provided by the companies listed. No endorsement or preference is intended. Extractable and leachable studies Extractable and leachable studies are integral to the development process for drug/device combination products. Designing and executing the right study, at the right time, can not only provide necessary safety data, but can also de-risk the overall program. Intertek's world-class E&L group works closely with its Inhaled and Nasal Centre of Excellence in Cam- bridge, UK, supporting all types of respiratory prod- ucts, including pressurized metered dose inhalers (pMDIs), soft mist inhalers (SMIs), nasal sprays, neb- ulizers and dry powder inhalers (DPIs). Intertek Pharmaceutical Services UK: +44 1763 261648 bd.melbourn@intertek.com www.intertek.com Hard two-piece capsules for inhaled drug delivery Many milestones are closely linked to the name of Qualicaps ® when looking back at the history of inhalation-grade capsules, including the first cap- sule developed for dry powder inhalers (DPIs). Since then, Qualicaps has continuously been developing new optimal solutions specially designed for inhaled drug delivery. As such, Qualicaps continues to inno- vate by expanding its portfolio with a range of extra dry capsules specifically designed for use in DPIs for moisture-sensitive and hygroscopic formulations. Qualicaps ® Europe Spain: +34 91 663 08 00 www.qualicaps.com